Symbiosal® and lowering of blood pressure and reduced risk of hypertension: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
Sign Up to like & getrecommendations! Published in 2018 at "EFSA Journal"
DOI: 10.2903/j.efsa.2018.5364
Abstract: Abstract Following an application from Han‐Biotech GmbH, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSA Panel on Dietetic Products,… read more here.
Keywords: symbiosal; health claim; blood pressure; lowering blood ... See more keywords